John Kokkinos
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer.
Journal: Oncogene
Published: September 17, 2025
βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer.
Journal: Cell death & disease
Published: August 04, 2025
CRO-67 has anti-cancer activity in pancreatic tumor cells and stromal cancer-associated fibroblasts.
CRO-67 has anti-cancer activity in pancreatic tumor cells and stromal cancer-associated fibroblasts.
Journal: Scientific reports
Published: April 01, 2025
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability.
Journal: Neoplasia (New York, N.Y.)
Published: December 03, 2024
Development of a long term, ex vivo, patient-derived explant model of endometrial cancer.
Journal: PloS one
Published: September 24, 2023
Ex vivo culture of intact human patient derived pancreatic tumour tissue.
Journal: Scientific reports
Published: June 25, 2020
Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs.
Journal: Biomaterials
Published: August 01, 2019
Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.
Journal: Atherosclerosis
Published: March 30, 2019
Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis.
Journal: Atherosclerosis
Published: July 27, 2018
The role of fibroblast growth factor 21 in atherosclerosis.
Journal: Atherosclerosis
Published: September 21, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026